Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1

National Institute on Drug Abuse (NIDA)

Overview

The purpose of this study is the use of buprenorphine/naloxone in treatment of opioid dependence.

The objective of this study is to determine the safety and efficacy of a buprenorphine/naloxone combination tablet for opiate dependence treatment.

Study Type

INTERVENTIONAL

Purpose

TREATMENT

Masking

DOUBLE

Conditions

Heroin Dependence Substance-Related Disorders

Interventions

Buprenorphine/naloxoneDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 59 Years

Medical Language ↔ Plain English

Inclusion Criteria: DSM-IV diagnosis of current opiate dependence males and non-pregnant, non-nursing female 18-59 yrs of age Exclusion Criteria: Any significant medical condition AST or ALT levels greater than 3x's the upper limit of normal level Current Axis I diagnosis other than opiate, caffeine or nicotine dependence

Locations (1)

New York MDRU

New York, New York, United States

Outcomes

Primary Outcomes

Craving

Drug use

Retention

Opioid withdrawal

Subjective rating

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.